Medicine composition for treating gastritis and peptic ulcer and preparation method thereof

Abstract

The invention discloses a preparation with the function of treating gastric ulcer caused by peptic gastric ulcer and a preparation method thereof. The formulation is prepared by 14 traditional Chinesemedicine bulk drugs including astragalus root, prepared rhizome of rehmannia, bighead atractylodes rhizome, pseudo-ginseng, rhizoma corydalis, bletilla striata, elecampane, daemonorops draco, cinnamon, frankincense, ramulus acaciae, calcined flute, centipede and deerhorn gelatin, and extractives of the traditional Chinese medicine bulk drugs. The formulation plays roles of Warming Yang, tonifyingspleen and activating Qi, nourishing flood, removing blood stasis, promoting tissue regeneration and alleviating pain and is used for treating gastric cavity secret anguish, warming and massage enjoyment, paroxysm or aggravation with cold and cool or fatigue, severe pain with limosis, pain relief with eating food and abdomen bloating after a meal which are caused by peptic ulcer deficiency-cold as well as limb cooling, fatigue, inappetence, loose stool and clear water or pantothenic acid vomiting and chronic gastritis caused by Helicobacter pylori. The invention also discloses a preparation method and a quality control method of the preparation.

Description

technical field [0001] The invention relates to a pharmaceutical preparation for treating peptic gastric ulcer and a preparation method thereof, belonging to the field of traditional Chinese medicines. Background technique [0002] In recent years, drugs for the treatment of peptic ulcers have developed rapidly, and the oldest antacids still have a certain status in the treatment of peptic ulcers. The advent of H2 receptor antagonists in the 1970s was a milestone in the development of the treatment of peptic ulcer disease. It has achieved good clinical efficacy and significantly reduced the incidence of peptic ulcer complications, so that a large number of patients can avoid surgery. H+_K+_ATPase (proton pump) inhibitors came out in the 1980s, first-generation omeprazole, second-generation lansoprazole, and pentoprazole. Proton pump inhibitors have stronger and more durable acid-suppressing effects than histamine H2 receptor blockers, and their curative effect on peptic ul...

AI Technical Summary

Problems solved by technology

Although some varieties on the market have overcome the disadvantages of quick onset of chemical drugs but high toxicity and side effects, few Chinese patent medicines currently on the market can effectively inhibit and kill Helicobacter pylori, and some of them just exaggerate the curative effect when advertising. There is no pharmacodynamic experiment as the basis in the world, so it has become necessary to develop a Chinese patent medicine preparation with reliable curative effect, no toxic and side effects, wide application range, and can treat peptic ulcer and chronic gastritis of deficiency-cold syndrome at the same time.

Images